Public trial registry of the CCC-Munich

Trial AGO-TR1 BRCA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AGO-TR1 BRCA
World
Full title
:

BRCA-Screening bei Eierstockkrebs-Prävalenz von BRCA bei Patienten mit primärem oder platinsensitivem rezidivierendem Ovarialkarzinom

World
Description
:

Primary diagnosis or platinum-sensetive recurrence in patients with epithelial invasive ovarian cancer.
Primärdiagnose oder platinsensitives Rezidiv bei Patienten mit epithelialem invasivem Ovarialkarzinom.

World
NCT number
:
World
Responsible organization
:
Frauenklinik GH, Telefon: 089440076800
Indications
Classification Code Description
ICD-10-GM C56 Bösartige Neubildung des Ovars
- Gynecological tumor
Trial design
World
Blinding type
:
Open
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2021-04-01 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator Alexander Burges Keine Organisationseinheit angegeben Magnifier